TNP方案在头颈部鳞状细胞癌中的疗效探讨

doi:10.11904/j.issn.1002-3070.2014.06.012

Abstract

Abstract:

Objective Our retrospective study is aimed to compare the effect and the adverse reaction of TNP(paclitaxel liposome + nedaplatin + tegafur)and PF(fluorouracil + cisplatin)in the treatment of head and neck squamous cell carcinoma(SCCHN).Methods Clinical data of patients with SCCHN received treatment at our hospital from 2009 to 2014 was retrospectively analyzed.Patients were divided into PF group and TNP group according to the treatment prescription.The general data,clinical features,treatment and the adverse reactions of the two groups were compared.Results A total of 54 patients was retrospective analyzed,including 27 patients in TNP group and 27 in PF group.There was no significant differences in clinical data between the two groups.There was no significant differences in the location of the tumor,clinical stage and differentiation degree between the two groups.The curative effect of TNP group was significantly ameliorated than the PF group.The incidence of gastrointestinal reaction in TNP group was obviously lower than in PF group.There was no significant differences in the other adverse reactions.Conclusion In the treatment of SCCHN,TNP regimen is more effective than PF regimen,and the incidence of gastrointestinal adverse reaction during the treatment is lower.

Key words: Head and neck squamous cell carcinoma, Neoadjuvant chemotherapy, Curative effect analysis

CLC Number:

R739.91

NING Siqing,ZHAN Botao,XU haisheng. The investigation of effects of TNP in the head and neck squamous cell carcinoma[J]. PRACTICAL ONCOLOGY JOURNAL, 2014, 28(6): 540-544.

References

1 Machiels JP,Schmitz S.Molecular-targeted therapy of head and neck squamous cell carcinoma:beyond cetuximab-based therapy[J].Curr Opin Oncol,2011,23(3):241-248.
2 Kikuchi M,Shinohara S,Nakamoto Y,et al.Sequential FDG-PET/CT after neoadjuvant chemotherapy is a predictor of histopathologic response in patients with head and neck squamous cell carcinoma[J].Mol Imaging Biol,2011,13(2):368-377.
3 Yamane T,Kikuchi M,Shinohara S,et al.Reduction of [(18)F]fluoromisonidazole uptake after neoadjuvant chemotherapy for head and neck squamous cell carcinoma[J].Mol Imaging Biol,2011,13(2):227-231.
4 Sato D,Kogashiwa Y,Tsukahara K,et al.Phase I study of nedaplatin prior to S-1 in patients with locally advanced head and neck squamous cell carcinoma[J].Chemotherapy,2013,59(4):314-318.
5 李杰.新辅助化疗对进展期乳腺癌患者 CD46表达影响及临床预后预测意义的研究[J].实用肿瘤学杂志,2014,(2):123-128.
6 张乃千,陶维阳,史蓬亮,等.新辅助化疗对乳腺癌分子表型的影响[J].实用肿瘤学杂志,2013,27(2):160-164.
7 Kikuchi M,Nakamoto Y,Shinohara S,et al.Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma[J].Int J Clin Oncol,2013,18(3):402-410.
8 Zhang XR,Liu ZM,Liu XK,et al.Influence of pathologic complete response to neoadjuvant chemotherapy on long-term survival of patients with advanced head and neck squamous cell carcinoma[J].Oral Surg Oral Med Oral Pathol Oral Radiol,2013,115(2):218-223.
9 邱杰,张文伟.头颈癌的治疗进展[J].实用肿瘤学杂志,2002,16(3):240-242.
10 方凤琴,黄金颖,刘文中,等.头颈鳞癌p53、Bcl-2及P-gp表达在治疗中的作用[J].实用肿瘤学杂志,2007,21(6):516-518.
11 Chen H,Zhou L,Chen D,et al.Clinical efficacy of neoadjuvant chemotherapy with platinum-based regimen for patients with locoregionally advanced head and neck squamous cell carcinoma:an evidence-based meta-analysis[J].Ann Saudi Med,2011,31(5):502-512.
12 Sharma AK,Mishra P,Gupta S.Immunohistochemistry,a valuable tool in detection of cervical lymph node micrometastases in head and neck squamous cell carcinoma:a prospective study[J].Indian J Otolaryngol Head Neck Surg,2013,65(Suppl 1):89-94.

[1]	LI Yujiao, SHANG Naijian. Research progress of imaging evaluation of neoadjuvant chemotherapy in breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 63-67.
[2]	CHEN Li, ZHANG Yuxin, ZUO Yanjiao, MA Fei, SONG Hongjiang, XUE Yingwei. The comparison of clinical efficacy of SOX and XELOX in the neoadjuvant chemotherapy for advanced gastric carcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(1): 23-30.
[3]	DAI Meng, LI Rui, LIU Guiting, LIANG Jinlong, FENG Jinfa, XU Shanyong. The feasibility analysis of breast conserving surgery after neoadjuvant chemotherapy in the treatment with advanced breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(2): 109-113.
[4]	BA Zhichang, WANG Xinxin, CUI Wanhui, GUO Fei, ZHANG Xiushi. Value of diffusion weighted magnetic resonance imaging in the monitoring of neoadjuvant chemotherapy efficacy for uterine cervical cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(6): 518-522.
[5]	ZHU Hong,ZHU Li,HAN Shiyu,FANG Fang,YU Yang. The predictive value of DWI for progression free survival in patients with cervix cancer after neoadjuvant chemotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2014, 28(6): 519-523.
[6]	SONG Yulin,WANG Jing. The screening and assessment of the neoadjuvant chemotherapy for the ovarian cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2014, 28(6): 553-556.
[7]	MA Rong,CHEN Xihai,GENG Xiaoxing,LIU Shuang,ZHANG Heng. The evaluation of effectiveness of concurrent chemoradiation for locally advanced cervical cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2012, 26(4): 314-318.
[8]	TENG Chong,SONG Xiaowei,CAI Li. Effect and clinical significance of Ki-67 in neoadjuvant chemotherapy for breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2012, 26(2): 188-192.
[9]	YIN Mingzhu,LOU Ge,CHEN Xiuwei,GU Taihua. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with concurrent chemoradiotherapy on locally advanced uterine cervix cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2011, 25(1): 40-45.
[10]	WU Liangzhi, JIANG Nan, ZHANG Yi. Study on the molecule mechanisms efficacy of two kinds of neoadjuvant chemotherapy in locally and advanced cervix cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2009, 23(5): 427-429.
[11]	XU Ye, GAO Ying, LOU Ge. A clinical observation on neoadjuvant chemotherapy for ovary tumor of advanced stage treated with paclitaxel liposome and nedaplatin [J]. PRACTICAL ONCOLOGY JOURNAL, 2008, 22(6): 512-513.

The investigation of effects of TNP in the head and neck squamous cell carcinoma

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 11

Recommended Articles

Metrics

Comments